fair point and that is the reason the sp is struggling to even reacg double digits. Fda clearance doesnt have any value unless sales is there … its no point valuating ldx at 0.17 upon fda clearance, all we need is solid sales and positive cash flow to be anywhere near 20c in future
Ann: Lumos Signs Major Development and IP Agreements with Hologic, page-116
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.3¢ |
Change
-0.001(2.94%) |
Mkt cap ! $18.57M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 3.7¢ | 3.3¢ | $88.56K | 2.536M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 1129869 | 3.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.5¢ | 123092 | 2 |
View Market Depth
| Last trade - 16.10pm 16/09/2024 (20 minute delay) ? |
| LDX (ASX) Chart |